What is the difference between Cabometyx and Cometriq?
Cabometyx and Cometriq are two brand name drugs that both contain the same active ingredient cabozantinib, a kinase inhibitor used to treat certain types of cancer. Cabozantinib inhibits multiple tyrosine kinases, including the MET, AXL and VEGF receptors.
Cabometyx and Cometriq are taken once per day and are both marketed by Exelixis in the US.
The two drugs are not bioequivalent however. That is to say, you can’t switch between the two brands.
Cabometyx and Cometriq come in different oral formulations and are used to treat different types of cancer
Cabometyx | Cometriq | |
Marketed since | 2016 | 2012 |
Dosage form | Tablets | Capsules |
Strength | 20, 40 and 60 mg | 20 and 80 mg |
Used to treat | | |
Related medical questions
- How long do you take it for?
- What is the success rate of Cabometyx (cabozantinib)?
- Does Cabometyx (cabozantinib) cure cancer?
- What is the difference between Cabometyx and Cometriq?
- How long do you take it for?
- What is the success rate of Cabometyx (cabozantinib)?
- Does Cabometyx (cabozantinib) cure cancer?
- What is the difference between Cabometyx and Cometriq?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions